Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT5 | Q11128 | 1/20 | 0.54 |
| ▸ | KRAS | P01116 | 11/20 | 0.53 |
| ▸ | TGM2 | P21980 | 1/20 | 0.51 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.46 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.46 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.46 |
| ▸ | HINT1 | P49773 | 3/20 | 0.46 |
| ▸ | FUT6 | P51993 | 1/20 | 0.45 |
| ▸ | NT5E | P21589 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25962870 | 0.89 | KRAS (0.48) | FUT5KRASTGM2P2RY2P2RY4 | |
| SCHEMBL25964115 | 0.89 | KRAS (0.49) | FUT5KRASTGM2P2RY2P2RY4 | |
| SCHEMBL25964287 | 0.86 | FUT5 (0.54) | FUT5KRASTGM2P2RY2P2RY4 | |
| SCHEMBL25964109 | 0.86 | FUT5 (0.62) | FUT5KRASTGM2P2RY2P2RY4 | |
| SCHEMBL25962160 | 0.86 | KRAS (0.47) | FUT5KRASTGM2P2RY2P2RY4 | |
| SCHEMBL25898025 | 0.84 | KRAS (0.59) | FUT5KRASTGM2HINT1FUT6 | |
| SCHEMBL25892798 | 0.84 | KRAS (0.61) | FUT5KRASTGM2P2RY2P2RY4 | |
| SCHEMBL25892795 | 0.84 | KRAS (0.61) | FUT5KRASTGM2P2RY2P2RY4 | |
| SCHEMBL25964288 | 0.83 | B4GALT1 (0.37) | FUT5KRASTGM2P2RY2P2RY4 | |
| SCHEMBL25892915 | 0.83 | KRAS (0.60) | FUT5KRASTGM2HINT1FUT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023141856-A1 | CD3-TARGETING MULTISPECIFIC ANTIBODY AND USE THEREOF | 岩唐生物科技(杭州)有限责任公司 | 2023-08-03 | — | — | WO | disclosed |